AMPHISTA THERAPEUTICS
Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.
AMPHISTA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2017-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.amphista.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag Google Universal Analytics Google Analytics 4
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Highlight Therapeutics
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
ppm.Ingredients
ppm.Ingredients operates as a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Series B - Amphista Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Amphista Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series B - Amphista Therapeutics
Gilde Healthcare
Gilde Healthcare investment in Series B - Amphista Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Amphista Therapeutics
BioMotiv
BioMotiv investment in Series B - Amphista Therapeutics
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series B - Amphista Therapeutics
BioMotiv
BioMotiv investment in Series A - Amphista Therapeutics
European Investment Fund
European Investment Fund investment in Series A - Amphista Therapeutics
Scottish Investment Bank
Scottish Investment Bank investment in Series A - Amphista Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-06 | Amphista Therapeutics Appoints Dr Martin Pass as CDO |
| 2021-09-21 | Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm |
| 2020-05-21 | Amphista Therapeutics Appoints Leading Protein Degradation Pioneer, Ian Churcher as CSO |
Official Site Inspections
http://www.amphista.com Semrush global rank: 7 M Semrush visits lastest month: 943
- Host name: 77.68.6.111
- IP address: 77.68.6.111
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Amphista Therapeutics"
Amphista Therapeutics - Crunchbase Company Profile …
Organization. Amphista Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Amphista | Advent Life Sciences
Amphista Therapeutics is using a novel mechanism of targeted protein degradation (TPD) to hijack the cell’s degradation machinery to modulate the abundance of proteins that are responsible for disease progression. Powered …See details»
Careers – Amphista Therapeutics
Amphista has assembled a world leading group of scientists and business leaders, working together to bring solutions to complex and challenging diseases, where patients have limited …See details»
Amphista Therapeutics - Funding, Financials, Valuation & Investors
Amphista Therapeutics operates as a biopharmaceutical company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. ...See details»
Org Chart Amphista Therapeutics - The Official Board
Organizational Chart of Amphista Therapeutics. Amphista Therapeutics www.amphista.com. has 15 executives +44 778 943 5990; Add an executive. Amphista Therapeutics News . Anything …See details»
Amphista Therapeutics - Company Profile - Tracxn
Amphista Therapeutics - Developer of targeted protein degradation technology-based therapeutics. Raised a total funding of $60.5M over 3 rounds from 9 investors. Valued at …See details»
Amphista Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Amphista Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Amphista Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Amphista Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Amphista Therapeutics Ltd. - Life-Sciences-Europe.com
Dec 20, 2017 Amphista is a spin-out of renowned TPD expert Professor Alessio Ciulli’s labs at the University of Dundee, and is based in BioCity Glasgow, Scotland. The company is funded …See details»
Amphista Therapeutics - VentureRadar
Amphista is a spin-out of TPD expert Professor Alessio Ciulli’s labs at the University of Dundee. Amphista is advancing a portfolio of drug candidates, initially focused in oncology, to address …See details»
Amphista Therapeutics - Contacts, Employees, Board Members
Organization. Amphista Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Number of …See details»
Amphista Therapeutics Limited - LinkedIn
This week, Dominic Owens, Senior Bioinformatician at Amphista Therapeutics, is Dresden, Germany for the 23rd Human Proteome Organization World Congress. This event serves as …See details»
Amphista Therapeutics | Novartis Venture Fund
Amphista Therapeutics is developing medicines for hard-to-treat diseases using next-generation targeted protein degradation approaches. Visit Amphista Therapeutics Legal [Footer Second]See details»
Amphista Therapeutics - Products, Competitors, Financials, …
Amphista Therapeutics focuses on the development of novel medicines in the pharmaceutical industry. Use the CB Insights Platform to explore Amphista Therapeutics's full profile. ... “We …See details»
AMPHISTA THERAPEUTICS LIMITED - Companies House
Charges for AMPHISTA THERAPEUTICS LIMITED (11119959) More for AMPHISTA THERAPEUTICS LIMITED (11119959) Registered office address The Cori Building Granta …See details»
Amphista Therapeutics - Overview, News & Similar companies
Jan 24, 2024 Who is Amphista Therapeutics. Amphista Therapeutics was founded in 2017 and is a biopharmaceutical company creating first-in-class therapeutics that help harness the …See details»
Amphista Therapeutics - Craft
Amphista Therapeutics has 5 employees across 2 locations and $60.5 m in total funding,. See insights on Amphista Therapeutics including office locations, competitors, revenue, financials, …See details»
Amphista Therapeutics - Gilde Healthcare
Amphista Therapeutics is a UK-based biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural processes to selectively and efficiently degrade …See details»
Amphista Therapeutics announces in vivo efficacy and CNS activity …
Jan 24, 2024 Louise Modis, Chief Scientific Officer of Amphista Therapeutics, said: “We are delighted by the progress we have made in advancing our pipeline and demonstrating the …See details»
Gilde Healthcare company Amphista Therapeutics enters a up to …
May 4, 2022 Amphista and Merck will collaborate to leverage Amphista’s proprietary EclipsysTM TPD platform and generate novel protein degrading therapeutics in oncology and immunology …See details»